Physician profile
Ziad A Ali
NPI 1588844245
$2,031,727.12
in general payments reported to CMS, 2019-2025
33 companies · $787K in 2025
The $787K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $171K · 2021: $126K · 2022: $274K · 2023: $317K · 2024: $248K · 2025: $787K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $674K · Travel and Lodging: $364K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $183K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Food and Beverage: $22K · Honoraria: $3,500 · Education: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $674,016.26 |
| Travel and Lodging | $363,757.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $183,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102,200.00 |
| Food and Beverage | $21,856.61 |
| Honoraria | $3,500.00 |
| Education | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,108,880.98 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $186,540.93 | 2021-2025 | (9520) Igt Devices Undivided, US Eq Undivided, Azurion 7 M12 |
| Abbott Laboratories | $178,974.75 | 2019-2025 | Optis, Coroflow, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals Lp | $152,285.23 | 2019-2024 | Brilinta, Farxiga, Airsupra |
| Boston Scientific Corporation | $150,665.70 | 2019-2025 | General - Vascular Access, General - Balloon Catheters, General - Balloons |
| Acist Medical Systems, INC. | $86,320.71 | 2019-2023 | |
| Abiomed | $47,197.41 | 2019-2025 | Impella |
| Heartflow, INC. | $42,810.29 | 2023-2025 | Ffrct |
| Amgen INC. | $20,616.29 | 2019-2025 | Repatha |
| Spectrawave, INC | $16,174.61 | 2023-2025 | Hypervue Imaging System, Starlight Imaging Catheter, X1-Ffr |
| Opsens INC. | $14,380.00 | 2019-2022 | |
| Cathworks, INC. | $13,980.03 | 2021-2025 | Ffrangio |
| Siemens Medical Solutions USA, INC. | $3,500.00 | 2021 | |
| Edwards Lifesciences Corporation | $3,168.17 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $3,135.34 | 2021-2025 | Symplicity G3, Onyx Frontier, Resolute Onyx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $612.69 | 2019-2020 | |
| Terumo Medical Corporation | $550.00 | 2025 | |
| Biotronik INC. | $351.00 | 2022-2025 | Recross, Nhancer Rx |
| Fresenius USA Marketing, INC. | $249.00 | 2021 | |
| Cardiovascular Systems INC. | $247.73 | 2019-2022 | |
| Neovasc Medical INC | $210.30 | 2022 | |
| Recor Medical INC | $156.85 | 2024 | Paradise Renal Denervation System |
| Asahi Intecc USA, INC. | $146.15 | 2025 | Asahi Coronary Wires |
| Zoll Circulation INC | $130.40 | 2020 | |
| Arrow International, INC. | $118.09 | 2021 | |
| Angiodynamics, INC. | $109.49 | 2024-2025 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $89.28 | 2022 | |
| Artivion, INC. | $35.17 | 2025 | Amds-Ascyrus Medical |
| Kestra Medical Technology Services, INC. | $31.02 | 2022 | |
| Ge Healthcare | $22.63 | 2025 | |
| Merck Sharp & Dohme LLC | $18.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$879,851.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.